US Pricing Squeeze Clouds Sun Pharma Q2; Site Re-Inspection Critical

 
• By Anju Ghangurde
MT1607_moneybox_1200x675
SUN REPORTED A TOUGH Q2 BUT EXPECTS A GRADUAL IMPROVEMENT IN THE SECOND HALF

More from Earnings

More from Business